Pharmaceuticals, Biotechnology and Life Sciences
WOODCLIFF LAKE, N.J., Oct. 21, 2025 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) is pleased…
CALGARY, Alberta, Oct. 20, 2025 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX…
EMERYVILLE, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) — NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) announces that…
Cash, cash equivalents, short-term investments and other liquid assets expected to fund operations into 2029, beyond anticipated top-line results from…
BioUcenta™ is the first biosimilar of Lucentis (ranibizumab) approved in AfricaKIGALI, Rwanda and SAN FRANCISCO, Oct. 20, 2025 (GLOBE NEWSWIRE)…
LOUISVILLE, Ky., Oct. 20, 2025 (GLOBE NEWSWIRE) — Onco360®, the nation’s leading independent specialty pharmacy, has been selected as a…
Teva and Prestige announce a license and supply agreement for the commercialization of Prestige’s Tuznue®, a biosimilar to Herceptin® (trastuzumab)…
New York, NY, Oct. 20, 2025 (GLOBE NEWSWIRE) — Lirum Therapeutics, Inc. (“Lirum”), an innovative clinical-stage biopharmaceutical company focused on…
AFFIRM-1 trial did not meet primary endpoint or secondary endpoints Company to conduct strategic review of portfolio and business operations…
Leadership team addition to drive strategic long-term value creation and partnering strategySOUTH SAN FRANCISCO, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE)…